Атеротромбоз is a peer-reviewed russian-language open-access journal published by Remedium Group LTD in Russian Federation, operating under an open-access model since 2013. The journal covers Internal medicine.
Authors publish in Атеротромбоз without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY-NC-ND license (see other journals using this license).
To date, Атеротромбоз has published 195 articles. Articles are minted with DOIs through the prefix 10.21518. All submissions undergo plagiarism screening before peer review.
Keywords
atherosclerosis, acute coronary syndrome, acute cerebrovascular disorder, antithrombotic therapy, anticoagulants
At a glance
- Publisher
- Remedium Group LTD
- Country
- Russian Federation
- Primary language
- Russian
- License
- CC BY-NC-ND
- Peer review
- Anonymous peer review
- OA since
- 2013
- Review time
- 8 weeks
- DOI prefix
10.21518- Plagiarism check
- Yes
ISSN
- 2307-1109
- electronic
- 2658-5952
Frequently asked questions
Is Атеротромбоз peer-reviewed?
Does Атеротромбоз charge an article processing charge (APC)?
What subjects does Атеротромбоз publish?
What languages does Атеротромбоз accept?
What is the ISSN of Атеротромбоз?
2307-1109 (print) · 2658-5952 (electronic).